Table 3.

Clinical score and the results of the nerve conduction study and electrochemical skin conductance between patients with diabetic and non-diabetic chronic kidney diseases.

	Diabetic CKD (n = 27)	Non-Diabetic CKD (n = 27)	p-Value
Toronto Clinical Neuropathy Score	5.7 ± 4.1	3.4 ± 3.0	0.02 *
Composite amplitude score	5.3 ± 3.2	3.2 ± 2.8	0.008 *
Median nerve, motor
DML	4.4 ± 0.6	4.1 ± 0.7	0.12
CMAP	8.5 ± 2.1	9.6 ± 2.9	0.12
MNCV	51.1 ± 4.3	52.9 ± 4.2	0.12
Ulnar nerve, motor
DML	3.1 ± 0.4	3.0 ± 0.4	0.17
CMAP	7.9 ± 2.3	9.8 ± 2.6	0.004 *
MNCV	51.3 ± 5.5	54.6 ± 4.9	0.02 *
Peroneal nerve,
DML	4.1 ± 0.6	3.8 ± 0.6	0.03 *
CMAP	2.4 ± 1.8	4.2 ± 2.7	0.004 *
MNCV	41.4 ± 4.3	46.0 ± 5.1	0.001 *
Tibial nerve
DML	4.2 ± 0.6	4.0 ± 0.5	0.06
CMAP	7.4 ± 5.3	8.7 ± 4.3	0.29
MNCV	41.3 ± 5.3	44.5 ± 3.3	0.01 *
Median nerve, sensory
Latency	3.3 ± 0.4	3.1 ± 0.5	0.04 *
SNAP	23.2 ± 13.2	30.4 ± 15.6	0.06
SNCV	42.6 ± 5.8	46.2 ± 7.8	0.04 *
Ulnar nerve, sensory
Latency	2.6 ± 0.4	2.4 ± 0.3	0.04 *
SNAP	17.8 ± 12.2	27.7 ± 13.5	0.004 *
SNCV	46.8 ± 6.4	49.8 ± 5.3	0.07
Sural nerve
Latency	3.1 ± 0.4	2.9 ± 0.3	0.07
SNAP	4.0 ± 2.7	9.9 ± 7.0	0.001 *
SNCV	44.8 ± 4.8	48.3 ± 5.3	0.04 *
Sudoscan
Hand ESC, µS	40.6 ± 19.7	45.7 ± 18.5	0.30
Feet ESC, µS	44.4 ± 18.2	48.4 ± 23.6	0.54

Data are presented as means ± standard deviations or n (%). * Indicates that p-value < 0.05. Abbreviations: n, number of cases; DML = distal motor latency; CMAP = compound muscles action potential; MNCV = motor nerve conduction velocity; SNAP = sensory nerve action potential; SNCV = sensory nerve conduction velocity; ESC, electro-chemical skin conductance.